Results 81 to 90 of about 7,770 (215)

Effect of antifibrinolytic drugs on transfusion requirement and blood loss during orthotopic liver transplantation: Results from a single center

open access: yesAsian Journal of Transfusion Science, 2008
Background: During orthotopic liver transplantation (OLT), activation of the fibrinolytic system can contribute significantly to perioperative bleeding.
Devi A   +4 more
doaj  

Uso tópico de agente antifibrinolítico na redução do sangramento após revascularização cirúrgica do miocárdio Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery

open access: yesBrazilian Journal of Cardiovascular Surgery, 2009
OBJETIVO: Verificar o efeito do uso tópico do ácido epsilon-aminocapróico (AEAC), aplicado na cavidade pericárdica, na redução do sangramento e necessidade de transfusão sanguínea no pós-operatório de revascularização cirúrgica do miocárdio.
João Roberto Breda   +7 more
doaj   +1 more source

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema [PDF]

open access: yes, 2010
Background We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angioedema: a current ...
Amin Kanani   +59 more
core   +3 more sources

Safety and Efficacy of Tranexamic Acid in Hepatic Surgery: Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesJournal of Surgical Oncology, Volume 133, Issue 5, Page 607-615, April 2026.
ABSTRACT Tranexamic acid (TXA) is widely used across surgical specialties to reduce perioperative blood loss, yet its specific role in hepatic resection remains unclear. This meta‐analysis, performed according to PRISMA guidelines, evaluated the efficacy and safety of TXA in liver surgery.
Haris Yaseen   +6 more
wiley   +1 more source

Topical vs. intravenous administration of tranexamic acid in knee arthroplasty and prevalence of deep venous thrombosis: a randomized clinical trial

open access: yesJornal Vascular Brasileiro
Background Tranexamic acid (TXA) is widely used in orthopedic surgery to reduce perioperative bleeding. Since TXA inhibits fibrinolysis, there is concern that it may increase the risk of thromboembolic events. Objectives To verify the prevalence of deep
Ari Zekcer   +4 more
doaj   +1 more source

Approach to Hemoptysis in the Modern Era

open access: yesCanadian Respiratory Journal, 2017
Hemoptysis is a frequent manifestation of a wide variety of diseases, with mild to life-threatening presentations. The diagnostic workup and the management of severe hemoptysis are often challenging.
Sébastien Gagnon   +4 more
doaj   +1 more source

Adaptation of Enhanced Recovery After Surgery Protocol for Elective Gastrointestinal and Hepatopancreaticobiliary Surgeries for Tertiary Hospitals in Ethiopia: A Modified Delphi Study

open access: yesWorld Journal of Surgery, Volume 50, Issue 4, Page 860-873, April 2026.
This adapted protocol consisting of 27 recommendations represents a critical step toward implementing standardized resource‐appropriate ERAS pathways for GI and HPB surgeries in Ethiopia. ABSTRACT Background Patients in low‐ and middle‐income countries (LMICs) lack access to safe and affordable surgical and anesthetic care.
Wongel Tena Shale   +7 more
wiley   +1 more source

Management of Antithrombotic Agents in Oral Surgery Maria Martinez and Dimitrios A. Tsakiris *

open access: yesDentistry Journal, 2015
Systemic anticoagulation with intravenous or oral anticoagulants and antiplatelet agents is an efficient treatment against thromboembolic or cardiovascular disease.
Maria Martinez, Dimitrios A. Tsakiris
doaj   +1 more source

Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation [PDF]

open access: yes, 2006
Disseminated intravascular coagulation (DIC) is a disorder characterized by both acute generalized, widespread activation of coagulation, which results in thrombotic complications due to the intravascular formation of fibrin, and diffuse hemorrhages, due
Franchini Massimo   +2 more
core   +2 more sources

Considerations for Menstrual Suppression in Patients With Hematologic Malignancies

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 3, March 2026.
ABSTRACT Patients who menstruate during treatment for hematologic malignancies have a higher risk of heavy vaginal bleeding due to thrombocytopenia caused by malignancy and myelosuppressive chemotherapy. Heavy menstrual bleeding is associated with significant morbidity in this patient population, and menstrual suppression is a standard of supportive ...
Sahaana Veeravalli   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy